2,136
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

The effect of insulin and kruppel like factor 10 on osteoblasts in the dental implant osseointegration in diabetes mellitus patients

, , , , &
Pages 14259-14269 | Received 06 Apr 2022, Accepted 26 May 2022, Published online: 22 Jun 2022

References

  • King GL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol. 2008;79:1527–1534.
  • Bouillon R. Diabetic bone disease. Calcif Tissue Int. 1991;49:155–160.
  • Kawaguchi H, Kurokawa T, Hanada K, et al. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology. 1994;135:774–781.
  • Lu H, Kraut D, Gerstenfeld LC, et al. Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. Endocrinology. 2003;144:346–352.
  • Mealey BL, Ocampo GL. Diabetes mellitus and periodontal disease. Periodontol 2000. 2007;44:127–153.
  • Shlossman M, Knowler WC, Pettitt DJ, et al. Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc. 1990;121:532–536.
  • Oates TW, Dowell S, Robinson M, et al. Glycemic control and implant stabilization in type 2 diabetes mellitus. J Dent Res. 2009;88:367–371.
  • Barewal RM, Oates TW, Meredith N, et al. Resonance frequency measurement of implant stability in vivo on implants with a sandblasted and acid-etched surface. Int J Oral Maxillofac Implants. 2003;18:641–651.
  • Bahendeka S, Kaushik R, Swai AB, et al. EADSG guidelines: insulin storage and optimisation of injection technique in diabetes management. Diabetes Therapy. 2019;10:341–366.
  • de Morais JA, Trindade-Suedam IK, Pepato MT, et al. Effect of diabetes mellitus and insulin therapy on bone density around osseointegrated dental implants: a digital subtraction radiography study in rats. Clin Oral Implants Res. 2009;20:796–801.
  • McCracken MS, Aponte-Wesson R, Chavali R, et al. Bone associated with implants in diabetic and insulin-treated rats. Clin Oral Implants Res. 2006;17:495–500.
  • de Molon RS, Morais-Camilo JA, Verzola MH, et al. Impact of diabetes mellitus and metabolic control on bone healing around osseointegrated implants: removal torque and histomorphometric analysis in rats. Clin Oral Implants Res. 2013;24:831–837.
  • Zhang J, Wang YN, Jia T, et al. Genipin and insulin combined treatment improves implant osseointegration in type 2 diabetic rats. J Orthop Surg Res. 2021;16:59.
  • Zhang N, Jiang H, Bai Y, et al. The molecular mechanism study of insulin on proliferation and differentiation of osteoblasts under high glucose conditions. Cell Biochem Funct. 2019;37:385–394.
  • Subramaniam M, Harris SA, Oursler MJ, et al. Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res. 1995;23:4907–4912.
  • Subramaniam M, Hawse JR, Rajamannan NM, et al. Functional role of KLF10 in multiple disease processes. BioFactors (OxfordEngland). 2010;36:8–18.
  • McConnell BB, Yang VW. Mammalian Krüppel-like factors in health and diseases. Physiol Rev. 2010;90:1337–1381.
  • Yang X, Chen Q, Sun L, et al. KLF10 transcription factor regulates hepatic glucose metabolism in mice. Diabetologia. 2017;60:2443–2452.
  • Yang N, Liu D, Zhang X, et al. Effects of ginsenosides on bone remodelling for novel drug applications: a review. Chin med. 2020;15:42.
  • Wang S, Zha X, Ruan S, et al. Kruppel like factor 10 up-regulates PDZ and LIM domain containing protein 2 via nuclear factor kappa-B pathway to inhibit proliferation and inflammatory of fibroblastoid synovial cell in rheumatoid arthritis. Bioengineered. 2022;13:1779–1790.
  • Li X, Liao Z, Deng Z, et al. Combining bulk and single-cell RNA-sequencing data to reveal gene expression pattern of chondrocytes in the osteoarthritic knee. Bioengineered. 2021;12:997–1007.
  • Lin CL, Hsu YC, Huang YT, et al. A KDM6A-KLF10 reinforcing feedback mechanism aggravates diabetic podocyte dysfunction. EMBO Mol Med. 2019;11:e9828
  • Yerges LM, Klei L, Cauley JA, et al. Candidate gene analysis of femoral neck trabecular and cortical volumetric bone mineral density in older men. J Bone Miner Res. 2010;25:330–338.
  • Chen Z, Li W, Wang H, et al. Klf10 regulates odontoblast differentiation and mineralization via promoting expression of dentin matrix protein 1 and dentin sialophosphoprotein genes. Cell Tissue Res. 2016;363:385–398.
  • Guan CP, Lin FQ, Hong WS, et al. Expression of InnVit/FBXO11 in vitiligo and its role in tyrosinase export from endoplasmic reticulum. Zhonghua Yi Xue Za Zhi. 2010;90:1126–1130.
  • Li Y, Bian M, Zhou Z, et al. Circular RNA SIPA1L1 regulates osteoblastic differentiation of stem cells from apical papilla via miR-204-5p/ALPL pathway. Stem Cell Res Ther. 2020;11:461.
  • Zhang Y, Zhang ZN, Li N, et al. Nbr1-regulated autophagy in Lactoferrin-induced osteoblastic differentiation. Biosci Biotechnol Biochem. 2020;84:1191–1200.
  • Mohammadi A, Mansoori B, Savadi P. Targeting of high mobility group A2 by small interfering RNA-loaded nanoliposome-induced apoptosis and migration inhibition in gastrointestinal cancer cells. J Cell Biochem. 2019;120:9203–9212.
  • Liu X, Zhou Y. Downregulation of lncRNA ANRIL inhibits osteogenic differentiation of periodontal ligament cells via sponging miR-7 through NF-κB pathway. Anal Cell Pathol (Amst). 2021;2021:7890674.
  • Lane TF, Sage EH. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 1994;8:163–173.
  • Sage EH. Terms of attachment: SPARC and tumorigenesis. Nat Med. 1997;3:144–146.
  • Basu A, Kligman LH, Samulewicz SJ, et al. Impaired wound healing in mice deficient in a matricellular protein SPARC (osteonectin, BM-40). BMC Cell Biol. 2001;2:15.
  • Delany AM, Amling M, Priemel M, et al. Osteopenia and decreased bone formation in osteonectin-deficient mice. J Clin Invest. 2000;105:915–923.
  • Kos K, Wong S, Tan B, et al. Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucose. Diabetes. 2009;58:1780–1788.
  • Yang L, Hai Y, Zhou JL. Osteoprotegerin and osteoprotegerin ligand expression during human marrow stromal cell differentiation and their effect on osteoclast formation. Chin Med J (Engl). 2011;124:2033–2037.
  • Kiechl S, Wittmann J, Giaccari A, et al. Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nat Med. 2013;19:358–363.
  • Wang L, Gao Z, Liu C, et al. Potential biomarkers of abnormal osseointegration of implants in type II diabetes mellitus. BMC Oral Health. 2021;21:583.
  • Napoli N, Chandran M, Pierroz DD, et al. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. 2017;13:208–219.
  • McCabe L, Zhang J, Raehtz S. Understanding the skeletal pathology of type 1 and 2 diabetes mellitus. Crit Rev Eukaryot Gene Expr. 2011;21:187–206.
  • Weber DR, Schwartz G. Epidemiology of skeletal health in Type 1 diabetes. Curr Osteoporos Rep. 2016;14:327–336.
  • Weber DR, Haynes K, Leonard MB, et al. Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using The Health Improvement Network (THIN). Diabetes Care. 2015;38:1913–1920.
  • Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89:309–319.
  • Pearson R, Fleetwood J, Eaton S, et al. Krüppel-like transcription factors: a functional family. Int J Biochem Cell Biol. 2008;40:1996–2001.
  • Iizuka K, Takeda J, Horikawa Y. Krüppel-like factor-10 is directly regulated by carbohydrate response element-binding protein in rat primary hepatocytes. Biochem Biophys Res Commun. 2011;412:638–643.
  • Coletta DK, Balas B, Chavez AO, et al. Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo. Am J Physiol Endocrinol Metab. 2008;294:E910–7.
  • Gutierrez-Aguilar R, Benmezroua Y, Balkau B, et al. Minor contribution of SMAD7 and KLF10 variants to genetic susceptibility of type 2 diabetes. Diabetes Metab. 2007;33:372–378.
  • Subramaniam M, Cicek M, Pitel KS, et al. TIEG1 modulates β-catenin sub-cellular localization and enhances Wnt signaling in bone. Nucleic Acids Res. 2017;45:5170–5182.
  • Subramaniam M, Hawse JR, Bruinsma ES, et al. TGFbeta inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts. Biochem Biophys Res Commun. 2010;392:72–76.
  • Subramaniam M, Gorny G, Johnsen SA, et al. TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro. Mol Cell Biol. 2005;25:1191–1199.
  • Ren Y, Zhang K, Wang J, et al. HOTAIRM1 promotes osteogenic differentiation and alleviates osteoclast differentiation by inactivating the NF-κB pathway. Acta Biochim Biophys Sin (Shanghai). 2021;53:201–211.
  • Xu J, Wu HF, Ang ES, et al. NF-kappaB modulators in osteolytic bone diseases. Cytokine Growth Factor Rev. 2009;20:7–17.
  • Abu-Amer Y. NF-κB signaling and bone resorption. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. Osteoporos Int. 2013;24:2377–2386.